NASDAQ · Medical - Devices

CTSO (CTSO) Stock

$0.35 -4.32% NASDAQ: CTSO Healthcare

Valuation

MetricValue
Price$0.35
Market Cap$22.25M
P/E Ratio-3.62
P/B Ratio4.92
P/S Ratio0.78
EPS (TTM)$0.00
52-Week High$1.39
52-Week Low$0.35
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-133.33%
ROA-18.18%
ROCE-233.33%
Gross Margin-37.84%
Operating Margin-37.84%
Net Margin-31.85%
Debt/Equity8.64
Current Ratio2.10

Annual Financials (USD)

Metric20212022202320242025
Revenue$40.0M$35.0M$31.0M$36.0M$37.0M
Operating Profit$-23.0M$-32.0M$-32.0M$-16.0M$-14.0M
Net Profit$-25.0M$-33.0M$-29.0M$-21.0M$-8.0M
EPS$-0.57$-0.75$-0.65$-0.38$-0.13
Op Margin-56.7%-90.9%-102.8%-46.2%-38.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$90.0M$63.0M$53.0M$47.0M$44.0M
Total Liabilities$27.0M$28.0M$30.0M$36.0M$38.0M
Cash$52.0M$22.0M$14.0M$3.0M$6.0M
Borrowings$14.0M$18.0M$18.0M$27.0M$29.0M

Latest News

CytoSorbents to Report Second Quarter 2026 Financial Results and Recent Business Highlights PR Newswire · Jul 20, 2026 OTC Markets Life Sciences Investor Forum: Dr. Phillip Chan, CEO, and Pete Mariani, CFO, of CytoSorbents with Zacks SCR’s Tom Kerr, CFA Zacks Small Cap Research · Jul 8, 2026 Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing GlobeNewswire · Jun 26, 2026 Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th GlobeNewswire · Jun 23, 2026 CytoSorbents to Present at the Life Sciences Forum on June 24, 2026 and Meet Virtually with Investors on June 30, 2026 GlobeNewswire · Jun 18, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-14.0M$-28.0M$-22.0M$-14.0M$-12.0M
Investing Cash Flow$-9.0M$-13.0M$-2.0M$-1.0M$-1.0M
Financing Cash Flow$0$0$0$-1.0M$0
Net Cash Flow$-18.0M$-30.0M$-8.0M$-6.0M$-2.0M
Free Cash Flow$-18.0M$-35.0M$-23.0M$-15.0M$-13.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-35.26%
Quick Ratio0.81
Interest Coverage-4.67
Return 1Y-62.24%
Return 3Y-88.89%
Return 5Y-94.94%

Ownership

Insiders Held15.72%
Institutions Held26.39%
Institutions Float Held31.31%
Institutional HolderSharesReport Date
Avenir Corp5,215,7762026-03-31
Vanguard Capital Management LLC1,879,9892026-03-31
Skylands Capital, LLC1,707,4982026-03-31
Neuberger Berman Group, LLC1,683,0072026-03-31
CM Management, LLC1,476,5002026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BDMD $1.07 +1.42% -1.68 $45.16M 0.00%
BDSX $20.38 -3.09% -2.82 $165.90M 0.00%
ECORelectroCore, Inc. $6.02 -2.75% -3.42 $49.94M 0.00%
ICCM $2.88 +3.23% -1.00 $6.49M 0.00%
MDAISpectral AI, Inc. $1.67 +1.79% -3.10 $53.12M 0.00%

About CTSO

CTSO is led by CEO Phillip Chan, employs 149 people, headquartered in US, publicly traded since 2006.

CTSO stock trades at $0.35 with a market capitalization of $22.25M. The stock is valued at a price-to-earnings (P/E) ratio of -3.62, price-to-book of 4.92, price-to-sales of 0.78. Over the past 52 weeks the stock has ranged between $0.35 and $1.39, and currently trades 74.8% below its 52-week high.

On profitability, CTSO generates a return on equity (ROE) of -133.33%, return on capital employed of -233.33%, an operating margin of -37.84%, a net profit margin of -31.85%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides